申请人:Fraley Mark E.
公开号:US20080274107A1
公开(公告)日:2008-11-06
The present invention relates to compounds which inhibit, regulate and/or modulate tyrosine kinase signal transduction, compositions which contain these compounds, and methods of using them to treat tyrosine kinase-dependent diseases and conditions, such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
本发明涉及抑制、调节和/或调节酪氨酸激酶信号传导的化合物,含有这些化合物的组合物,以及使用它们治疗哺乳动物中的酪氨酸激酶依赖性疾病和病状的方法,如血管生成、癌症、肿瘤生长、动脉硬化、年龄相关性黄斑变性、糖尿病视网膜病变、炎症性疾病等。